Novel alternative splice variants of rat phosphodiesterase 7B showing unique tissue-specific expression and phosphorylation

Biochemical Journal

Volumn 361, Issue 2, 2002, Pages 211-220

  Sasaki, Takashi ^a   Kotera, Jun ^a   Omori, Kenji ^a  

^a MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

Author keywords

Brain; In situ hybridization; Phosphodiesterase; Protein kinase A; Testis

Indexed keywords

HYBRIDIZATION ANALYSIS;

AMINO ACIDS; DNA SEQUENCES; ENZYMES; TISSUE;

GENETIC ENGINEERING;

COMPLEMENTARY DNA; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; ENZYME VARIANT; ISOBUTYLMETHYLXANTHINE; PHOSPHODIESTERASE; RECOMBINANT ENZYME;

AMINO ACID COMPOSITION; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL FUNCTION; CONTROLLED STUDY; CORPUS STRIATUM; ENZYME PHOSPHORYLATION; IN SITU HYBRIDIZATION; MALE; NONHUMAN; NORTHERN BLOTTING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; SPERMATOCYTE; SPERMATOGENESIS; TESTIS; TISSUE DISTRIBUTION; TISSUE SPECIFICITY;

3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BLOTTING, NORTHERN; BRAIN; COS CELLS; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DNA PRIMERS; DNA, COMPLEMENTARY; ENZYME INHIBITORS; IN SITU HYBRIDIZATION; KINETICS; MALE; MOLECULAR SEQUENCE DATA; MUSCLE, SKELETAL; PHOSPHORYLATION; POLYMERASE CHAIN REACTION; RATS; RNA, MESSENGER; SEQUENCE HOMOLOGY, AMINO ACID; SEQUENCE HOMOLOGY, NUCLEIC ACID; TESTIS;

ANIMALIA;

EID: 0037081859     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/0264-6021:3610211     Document Type: Article

References (43)

1. Cyclic nucleotide phosphodiesterases: Functional implications of multiple isoforms
2. Regulation of cAMP and cGMP signaling: New phosphodiesterases and new functions
3. Autosomal recessive retinitis pigmentosa caused by mutations in the alpha subunit of rod cGMP phosphodiesterase
4. Nitric oxide as a mediator of relaxation of the corpus cavernosum in response to nonadrenergic, noncholinergic neurotransmission
5. Impaired growth and fertility of cAMP-specific phosphodiesterase PDE4D-deficient mice
6. Attenuation of insulin secretion by insulin-like growth factor 1 is mediated through activation of phosphodiesterase 3B
7. CD3- and CD28-dependent induction of PDE7 required for T cell activation
8. Cyclic nucleotide phosphodiesterases: Relating structure and function
9. Cyclic nucleotide phosphodiesterases: Gene complexity, regulation by phosphorylation, and physiological implications
10. Isolation and characterization of two novel phosphodiesterase PDE11A variants showing unique structure and tissue-specific expression
11. Alternative splicing of the high affinity cAMP-specific phosphodiesterase (PDE7A) mRNA in human skeletal muscle and heart
12. Phosphorylation and activation of a cAMP-specific phosphodiesterase by the cAMP-dependent protein kinase. Involvement of serine 54 in the enzyme activation
13. Stimulation of p70S6 kinase via a growth hormone-controlled phosphatidylinositol 3-kinase pathway leads to the activation of a PDE4A cyclic AMP-specific phosphodiesterase in 3T3-F442A preadipocytes
14. The RACK1 signaling scaffold protein selectively interacts with the cAMP-specific phosphodiesterase PDE4D5 isoform
15. The MAP kinase ERK2 inhibits the cyclic AMP-specific phosphodiesterase HSPDE4D3 by phosphorylating it at Ser579
16. Identification of human PDE7B, a cAMP-specific phosphodiesterase
17. Cloning and characterization of PDE7B, a cAMP-specific phosphodiesterase
18. Cloning and characterization of a novel human phosphodiesterase that hydrolyzes both cAMP and cGMP (PDE10A)
19. 4
20. Structure, localization, and regulation of cGMP-inhibited phosphodiesterase (PDE3)
21. Phosphorylation of the gamma subunit of the retinal photoreceptor cGMP phosphodiesterase by the cAMP-dependent protein kinase and its effect on the gamma subunit interaction with other proteins
22. cAMP-specific phosphodiesterase HSPDE4D3 mutants which mimic activation and changes in rolipram inhibition triggered by protein kinase A phosphorylation of Ser-54: Generation of a molecular model
23. Short term feedback regulation of cAMP in FRTL-5 thyroid cells. Role of PDE4D3 phosphodiesterase activation
24. Phosphorylation-mediated activation and translocation of the cyclic AMP-specific phosphodiesterase PDE4D3 by cyclic AMP-dependent protein kinase and mitogen-activated protein kinases. A potential mechanism allowing for the coordinated regulation of PDE4D activity and targeting
25. 2-terminal UCR regions
26. Transcription factors responsive to cAMP
27. Regulation of the seminiferous epithelium
28. Modulation of basal and FSH-dependent cyclic AMP production in rat seminiferous tubules staged by an improved transillumination technique
29. Cloning and characterization of a cAMP-specific cyclic nucleotide phosphodiesterase
30. Stage and cell-specific expression of the adenosine 3′,5′ monophosphate-phosphodiesterase genes in the rat seminiferous epithelium
31. Type 4 cyclic adenosine monophosphate-specific phosphodiesterases are expressed in discrete subcellular compartments during rat spermiogenesis
32. Beyond the dopamine receptor: The DARPP-32/protein phosphatase-1 cascade
33. DARPP-32, a dopamine-regulated neuronal phosphoprotein, is a potent inhibitor of protein phosphatase-1
34. Modulation of calcium currents by a D1 dopaminergic protein kinase/phosphatase cascade in rat neostriatal neurons
35. 1 32 kDa)/protein phosphatase-1 pathway regulates dephosphorylation of the NMDA receptor
36. Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human Huntington disease gene
37. Severe deficiencies in dopamine signaling in presymptomatic Huntington's disease mice
38. Huntington's disease progression. PET and clinical observations
39. Expression of a calmodulin-dependent phosphodiesterase isoform (PDE1B1) correlates with brain regions having extensive dopaminergic innervation
40. Identification of two splice variant forms of type-IVB cyclic AMP phosphodiesterase, DPD (rPDE-IVB1) and PDE-4 (rPDE-IVB2) in brain: Selective localization in membrane and cytosolic compartments and differential expression in various brain regions
41. Isolation and characterization of a dual-substrate phosphodiesterase gene family: PDE10A
42. Changes in D2 but not D1 receptor binding in the striatum following a selective lesion of striatopallidal neurons
43. D1 and D2 dopamine receptor gene expression in the rat striatum: Sensitive cRNA probes demonstrate prominent segregation of D1 and D2 mRNAs in distinct neuronal populations of the dorsal and ventral striatum